Vinati Organics reported a 28% year-over-year revenue increase to ₹7 billion in Q1 FY27, driven by strong export sales and antioxidant demand. While currency fluctuations and higher raw material costs squeezed profit margins this quarter, the company maintains its full-year EBITDA margin guidance of 26-27%.
Vinati Organics Limited announced its financial performance for the first quarter of the 2027 fiscal year, showing a revenue of ₹7 billion. This represents a 28% growth compared to the same period last year and a 15% increase over the previous quarter. The growth was supported by solid demand in the antioxidant segment, which remains a key focus area for the company's expansion strategy.
Impact of Costs on Profit Margins
Despite the rise in revenue, the company faced pressure on its operating margins. The EBITDA margin, which measures core operational profitability, declined by 370 basis points compared to the preceding quarter. This dip was largely linked to two main problems: the weakening of the Indian Rupee, which affects the cost of imports and overall export dynamics, and an increase in raw material expenses.
However, management has expressed confidence in the company’s ability to recover. They have reaffirmed their EBITDA margin guidance for the full fiscal year 2027, aiming to keep it between 26% and 27%. The company expects that the second half of the year will show improved performance as some of these cost pressures potentially stabilize.
Expansion and Future Growth Projects
Vinati Organics is currently working on re-engineering its Veeral Organics plant. This project is on track, with the company expecting to finish the work by December 2026. If the timeline holds, the plant is set to start contributing to commercial revenue by January 2027. Once the plant reaches 80% of its capacity, it is estimated to bring in between ₹4 billion and ₹5 billion in annual revenue.
For the antioxidants division specifically, the company is aiming for a peak annual revenue potential of ₹7 billion. These projects are significant because they represent a major part of the company’s plan to move toward higher-value products and expand its market reach. For the full year, financial analysts are estimating a 13% growth in total revenue.
What Investors Should Monitor
Investors may want to track the actual commissioning date of the Veeral Organics facility, as any delay in this timeline could affect the revenue projections for the next fiscal year. Additionally, because the company relies heavily on exports, fluctuations in the currency exchange rate will continue to be a factor that influences profit margins. The primary monitorables will be whether the company can successfully manage its raw material costs and maintain its margin guidance as the new capacity comes online in early 2027.